Capital Analysts, LLC Horizon Therapeutics Public LTD CO Transaction History

Capital Analysts, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $21,517 - $31,533	271 Added 34.48%	1,057 $84,000
Q3 2021 Nov 04, 2021	BUY	$91.91 - $110.37 $19,484 - $23,398	212 Added 36.93%	786 $86,000
Q2 2021 Aug 05, 2021	BUY	$86.24 - $95.92 $49,501 - $55,058	574 New	574 $54,000
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $1.31 Million - $1.65 Million	-19,550 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $256,819 - $371,674	4,650 Added 31.21%	19,550 $1.52 Million
Q2 2020 Aug 07, 2020	BUY	$30.2 - $56.98 $238,580 - $450,142	7,900 Added 112.86%	14,900 $828,000
Q1 2020 May 08, 2020	SELL	$24.87 - $38.56 $80,827 - $125,320	-3,250 Reduced 31.71%	7,000 $207,000
Q4 2019 Feb 12, 2020	BUY	$25.43 - $36.67 $120,792 - $174,182	4,750 Added 86.36%	10,250 $371,000
Q3 2019 Nov 12, 2019	BUY	$23.0 - $27.97 $126,500 - $153,835	5,500 New	5,500 $149,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Analysts, LLC with notifications on news.